Insulet
PODD
NASDAQ
IPO2007
about PODD
Insulet is a company that develops and sells the Omnipod Insulin Therapy System, a tubeless insulin delivery system designed for people with diabetes to manage their condition without the need for traditional infusion pumps or multiple daily injections.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $226.14 | $230.43 | $216.49 | $15.5B | 2.12M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$1.24 | n/a | n/a | 16.66% | 12.40% | 0% |